DJIA 16,027.05 -177.92 -1.10%
NASDAQ 4,283.75 -79.39 -1.82%
S&P 500 1,853.44 -26.61 -1.42%
market minute promo

60.72 1.09 (1.83%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BMY $60.72 1.83%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $59.04
Previous Close $59.63
Daily Range $58.77 - $61.17
52-Week Range $51.82 - $70.87
Market Cap $101.3B
P/E Ratio 29.67
Dividend (Yield) $1.52 (2.5%)
Ex-Dividend Date
Dividend Pay Date
Volume 10,656,014
Average Daily Volume 7,726,856
Current FY EPS $1.89




Drug Makers

Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website:

News & Commentary Rss Feed

3 Potential Blockbusters Moving the Needle for Big Pharma in 2016

These pharmas have some recently approved drugs that could singlehandedly boost total sales this year.

Tracking Kahn Brothers Portfolio - Q4 2015 Update

Bristol-Myers' Daklinza-Sovaldi Label Expanded by the FDA

TapImmune Tackles Ovarian Cancer In Fast Track Phase II Clinical Trials

Waging War on the Greatest Cancer Myth of All

This common cancer belief lives on, but that doesn't mean it's true.

Upcoming Events - Bayer's Lung Cancer Effort And Apricus And Zealand Try Again

Why Achillion Pharmaceuticals Shares Crashed 37% in January

Investors continue to sell off the once-promising developer of hepatitis C drugs.

My Newest Sweet REIT Purchases: Welltower And National Health Investors

Is Big Pharma Hinting At A SMID-Cap Biotech Rally?

Why Medivation, Inc. Shares Crashed 32% in January

A delay to a key clinical trial weighed on shares last month.

See More BMY News...

BMY's Top Competitors

BMY $60.72 (1.83%)
Current stock: BMY
JNJ $102.00 (1.45%)
Current stock: JNJ
NVS $73.18 (-1.55%)
Current stock: NVS
RHHBY $31.25 (-1.39%)
Current stock: RHHBY